Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/25/2026

Propranolol as First‑Line Therapy for Essential Tremor

Indications and Guideline Recommendations

  • The 2022 Hypertension guideline recommends propranolol as a first‑line medication for essential tremor, citing its long‑standing efficacy and suitability for patients who also have hypertension. 1
  • Propranolol has been the gold‑standard treatment for essential tremor for more than four decades and remains the most effective first‑line option according to the same guideline. 2

Dual Therapeutic Benefit

  • In patients with both essential tremor and hypertension, propranolol provides simultaneous control of tremor amplitude and blood‑pressure reduction, allowing possible de‑escalation of other antihypertensive agents. 3

Initiation and Titration

  • Begin with a low dose (e.g., 20–40 mg twice daily or an equivalent long‑acting formulation once daily) and titrate upward based on tremor response and tolerability; target daily dose is typically 120–320 mg. (Dosing guidance derived from the Hypertension guideline.) 1
  • During titration, monitor for bradycardia, hypotension, and fatigue, adjusting the regimen as needed. 2

Contraindications and Safety Screening

Contraindication Reason Source
Asthma or severe bronchial disease Absolute contraindication to non‑selective β‑blockade [4]
Symptomatic bradycardia or second/third‑degree AV block Risk of worsening conduction abnormalities [4]
Decompensated heart failure β‑blockers may exacerbate low‑output states [4]

Follow‑Up and Monitoring Strategy

  • Re‑evaluate tremor severity 4–8 weeks after initiation using standardized clinical rating scales (e.g., hand‑tremor and disability scores). 5
  • Assess blood‑pressure control; propranolol may permit reduction or discontinuation of other antihypertensives such as calcium‑channel blockers. 1
  • Monitor heart rate, aiming for >60 bpm in older adults to avoid excessive bradycardia. 1

Avoiding Common Pitfalls

  • Do not discontinue propranolol abruptly; taper gradually to prevent rebound hypertension. 1
  • Screen for secondary causes of tremor, especially thyroid dysfunction, because hyperthyroidism can mimic or worsen essential tremor. 2
  • No clinically significant interaction between propranolol and gout therapy (e.g., allopurinol); however, periodic renal‑function checks are advisable. 6

Advanced Therapeutic Options for Refractory Cases

  • Thalamic deep brain stimulation can achieve approximately 90 % tremor reduction but requires referral to a neurosurgical specialist. 5